Skip to main content
Veterinary Medicines

STELLAMUNE MYCOPLASMA

Authorised
  • Mycoplasma hyopneumoniae, strain NL1042, Inactivated

Product identification

Medicine name:
STELLAMUNE MYCOPLASMA
Active substance:
  • Mycoplasma hyopneumoniae, strain NL1042, Inactivated
Target species:
  • Pig (piglet)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Mycoplasma hyopneumoniae, strain NL1042, Inactivated
    10.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    Dose
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig (piglet)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB13
Authorisation status:
  • Valid
Authorised in:
  • Spain
Available in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Elanco Animal Health Ireland Limited
  • Zoetis Belgium
  • Laboratorios Syva S.A.U.
  • Zoetis Belgium
Responsible authority:
  • Spanish Agency For Medicines And Health Products
Authorisation number:
  • 2639 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."